| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
transformation/transcription domain associated protein | 0.572 | 0.692 | 1.00 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
lysine demethylase 5C | 0.581 | 0.538 | 1.00 |
|
disease | 0.410 | None | 1.000 | 2 | 0 | 2008 | 2016 | ||||||||
|
phosphate cytidylyltransferase 2, ethanolamine | 0.821 | 0.192 | 8.6E-04 |
|
disease | 0.310 | strong | 1.000 | 2 | 0 | 2012 | 2019 | ||||||||
|
glycine receptor alpha 1 | 0.628 | 0.500 | 1.6E-04 |
|
disease | 0.310 | moderate | 1.000 | 2 | 0 | 1992 | 2017 | ||||||||
|
lysyl-tRNA synthetase 1 | 0.636 | 0.577 | 4.2E-09 |
|
disease | 0.400 | strong | 1.000 | 2 | 0 | 2015 | 2017 | ||||||||
|
zinc finger MIZ-type containing 1 | 0.588 | 0.615 | 1.00 |
|
disease | 0.410 | None | 1.000 | 2 | 0 | 2015 | 2019 | ||||||||
|
transient receptor potential cation channel subfamily M member 3 | 0.663 | 0.769 | 5.7E-07 |
|
disease | 0.400 | moderate | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
solute carrier family 5 member 6 | 0.674 | 0.577 | 6.1E-03 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
phosphatase and actin regulator 1 | 0.663 | 0.423 | 0.64 |
|
disease | 0.400 | strong | 1.000 | 2 | 0 | 2017 | 2017 | ||||||||
|
calcium voltage-gated channel subunit alpha1 B | 0.650 | 0.577 | 1.00 |
|
disease | 0.400 | strong | 1.000 | 2 | 0 | 2015 | 2019 | ||||||||
|
prolyl 4-hydroxylase, transmembrane | 0.666 | 0.500 | 3.9E-09 |
|
disease | 0.400 | strong | 1.000 | 2 | 0 | 2014 | 2019 | ||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2 | 0.644 | 0.615 | 1.00 |
|
disease | 0.410 | strong | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
vesicle associated membrane protein 2 | 0.650 | 0.462 | 0.89 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
spectrin beta, non-erythrocytic 2 | 0.619 | 0.731 | 9.9E-05 |
|
disease | 0.440 | moderate | 1.000 | 1 | 0 | 2013 | 2019 | ||||||||
|
arginyl-tRNA synthetase 1 | 0.604 | 0.538 | 3.3E-08 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
zinc finger protein 335 | 0.711 | 0.462 | 6.9E-07 |
|
disease | 0.300 | limited | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
SRY-box transcription factor 4 | 0.489 | 0.808 | 0.93 |
|
disease | 0.410 | strong | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 | 0.695 | 0.385 | 1.00 |
|
disease | 0.310 | strong | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
disease | 0.440 | strong | 1.000 | 1 | 0 | 2000 | 2019 | ||||||||
|
RNA polymerase II subunit A | 0.650 | 0.423 | 1.00 |
|
disease | 0.310 | strong | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
RAS like proto-oncogene A | 0.656 | 0.577 | 0.97 |
|
disease | 0.310 | strong | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
Rac family small GTPase 1 | 0.429 | 0.962 | 0.76 |
|
disease | 0.410 | strong | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
POU class 3 homeobox 3 | 0.682 | 0.615 | 0.88 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
GTP binding protein 2 | 0.736 | 0.423 | 0.32 |
|
disease | 0.400 | strong | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
tRNA isopentenyltransferase 1 | 0.621 | 0.692 | 4.1E-11 |
|
disease | 0.400 | strong | 1.000 | 1 | 0 | 2014 | 2014 |